Loading...
Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on Therapy
OBJECTIVES: Hydroxychloroquine (HCQ) 400 mg is approved by the Drug Controller General of India (DCGI) and recommended by the Research Society for the Study of Diabetes in India (RSSDI) clinical practice recommendations 2017 as add-on therapy after metformin and sulfonylurea in Type 2 Diabetes (T2DM...
Na minha lista:
| Udgivet i: | J ASEAN Fed Endocr Soc |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Journal of the ASEAN Federation of Endocrine Societies
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784185/ https://ncbi.nlm.nih.gov/pubmed/33442141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15605/jafes.034.01.13 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|